An International Network of field sites with continuous Demographic
Evaluation of Populations and Their Health in developing countries
 

Home

Vision

Objectives

Governance

INDEPTH DSS Sites

Contact Us

News

Events

FAQ

Publications

Feedback

Search

Filabavi DSS, Vietnam

 

FilaBavi is in Bavi District of Ha Tay Province in northern Viet Nam. The site is 60 km west of Hanoi. The Filabavi DSS was initiated in 1999. The whole population of Bavi District is approximately 240 000, and the initial population under surveillance was 51 024 (11 089 households), about 21% of the district’s population. Bavi District has 32 commune health stations (CHSs), one in each commune. Twenty-one of these CHSs are under the direct supervision of the Bavi District Health Centre, and three intercommunal polyclinics supervise and support the 11 others. 

 

Objectives

The overall objective of the FilaBavi DSS is to develop an epidemiological surveillance system in Bavi to:

  • Generate basic health data;

  • Supply information for health planning;

  • Serve as a background and sampling frame for specific studies, especially intervention studies; and

  • Constitute a setting for epidemiological training of research students.

 

Specific objectives

  1. To develop an epidemiological surveillance system in a representative sample of the population in Bavi;

  2. To generate basic health data (for example, on fertility and mortality) for health planning;

  3. To provide household and individual background data, a sampling frame, and a professional field organization for specific studies to economize on resources and increase cost-effectiveness in research and research training;

  4. To provide a setting for epidemiological training for Vietnamese and Swedish research students; and

  5. To serve as an appropriate setting for intervention studies (based on findings generated by the field laboratory) and health-priority discussions with the population and relevant authorities. 

 

Primary areas of research

  • Health care utilisation and equity

  • Epidemiological diseases in transition period

  • NCD

  • Rational Use of Drug

 

Back to DSS sites